Glyna
just one very small problem with you arguement
CHM gained nothing from these transactions
MMX gained significantly
CHM whole arguement is that Barnes and Grimaldi (acting as a defacto officer of CHM) used their position in CHM for their benefit and for the benefit of a third party that is MMX.
MMX benefit was that it was able to make the critical cash payments to secure the project. CHM contend that without this MMX would have no project.
The whole arguement about if CHM had knowledge is a nonsense. New management of CHM are saying that old CHM management ripped the company off and this was done in conjection with MMX for MMX benefit.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Glynajust one very small problem with you arguementCHM gained...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $19.57K | 4.893M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 419507 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18587873 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 419507 | 0.004 |
39 | 26659272 | 0.003 |
15 | 14700506 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 17587873 | 20 |
0.006 | 13115184 | 13 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2390797 | 5 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online